Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the effective dose(s) of RPC4046 in the treatment of Eosinophilic Esophagitis (EoE). This trial consists of two phases: 16 weeks of double-blind treatment and...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Celgene
NCT02504853 · Food Allergy, Loeys-Dietz Syndrome, and more
NCT07112378 · Eosinophilic Esophagitis (EoE)
NCT06693531 · Eosinophilic Esophagitis (EoE)
NCT05199532 · Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, and more
NCT06596252 · Eosinophilic Esophagitis
Mayo Clinic - Arizona
Scottsdale, Arizona
Desert Sun Clinical Research, LLC
Tucson, Arizona
Alliance Clinical Research
Oceanside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions